Novotech Backs Approval of Anlotinib Combination for Soft Tissue Sarcoma
August 29, 2025
Novotech, a globally recognized full-service clinical research organization (CRO), is proud to have partnered with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ Pharma) in